Enteropathy-associated T-cell lymphoma natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Enteropathy-associated T-cell lymphoma}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing....") |
Nima Nasiri (talk | contribs) No edit summary |
||
(20 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Enteropathy-associated T-cell lymphoma}} | {{Enteropathy-associated T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{Nnasiri}} | |||
==Overview== | |||
Enteropathy-associated T-cell lymphoma is usually a fast-growing (aggressive) lymphoma. Common complications of enteropathy-associated T-cell lymphoma include [[ulcer]], [[obstruction]], and [[perforation]] of [[small intestine]]. Prognosis is generally poor. | |||
==Natural History== | |||
* Enteropathy-associated T-cell lymphoma is usually a fast-growing (aggressive) lymphoma.<ref name="canadiancancer">Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref> | |||
* It is associated with [[celiac disease]] (sprue). | |||
* Most adults are diagnosed with [[celiac disease]] at the same time as their lymphoma or shortly before their lymphoma is diagnosed. | |||
* Enteropathy-associated T-cell lymphoma may spread to the [[Liver|liver,]] [[spleen]], [[lymph nodes]], [[gallbladder]], [[stomach]], colon or skin. | |||
==Complications== | |||
* Common complications of enteropathy-associated T-cell lymphoma include:<ref name="canadiancancer">Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref><ref name="pmid30302434">{{cite journal |vauthors=Kabul S, Uğraş N, Yerci Ö, Öztürk E |title=Perforation of the small intestine caused by enteropathy-associated T cell lymphoma |journal=Turk J Surg |volume=34 |issue=3 |pages=253–255 |date=2018 |pmid=30302434 |pmc=6173604 |doi=10.5152/turkjsurg.2017.3278 |url=}}</ref> | |||
:* [[Ulcer]] in small intestine | |||
:* [[Obstruction]] of small intestine | |||
:* [[Perforation]] of small intestine | |||
==Prognosis== | |||
* The prognosis for people with enteropathy-associated T-cell lymphoma is often not very good.<ref name="canadiancancer">Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref><ref name="pmid25716069">{{cite journal |vauthors=Nijeboer P, de Baaij LR, Visser O, Witte BI, Cillessen SA, Mulder CJ, Bouma G |title=Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort |journal=Am. J. Hematol. |volume=90 |issue=6 |pages=493–8 |date=June 2015 |pmid=25716069 |doi=10.1002/ajh.23992 |url=}}</ref> | |||
* Recurrences most frequent in the small intestine.<ref name="cancer.gov">Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 27, 2016</ref> | |||
* The most influential prognostic factor is bulky nature of disease, defined by a tumor mass greater than 5 cm. <ref name="pmid21566094">{{cite journal |vauthors=Delabie J, etal |title=Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project|journal=Blood |volume=118|issue=148|pages= 148|date=July 2011 |doi=10.1182/blood-2011-02-335216}}</ref> <ref name="KumarBurger2016">{{cite journal|last1=Kumar|first1=A.|last2=Burger|first2=I. A.|last3=Zhang|first3=Z.|last4=Drill|first4=E. N.|last5=Migliacci|first5=J. C.|last6=Ng|first6=A.|last7=LaCasce|first7=A.|last8=Wall|first8=D.|last9=Witzig|first9=T. E.|last10=Ristow|first10=K.|last11=Yahalom|first11=J.|last12=Moskowitz|first12=C. H.|last13=Zelenetz|first13=A. D.|title=Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes|journal=Haematologica|volume=101|issue=10|year=2016|pages=1237–1243|issn=0390-6078|doi=10.3324/haematol.2016.141846}}</ref> | |||
* Autologous [[stem cell]] [[transplantation]] is a useful way of treatment for selected patients with enteropathy-associated T-cell lymphoma and can control disease progress. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] |
Latest revision as of 17:30, 6 March 2019
Enteropathy-associated T-cell lymphoma Microchapters |
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Enteropathy-associated T-cell lymphoma natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma natural history, complications and prognosis |
FDA on Enteropathy-associated T-cell lymphoma natural history, complications and prognosis |
CDC on Enteropathy-associated T-cell lymphoma natural history, complications and prognosis |
Enteropathy-associated T-cell lymphoma natural history, complications and prognosis in the news |
Blogs on Enteropathy-associated T-cell lymphoma natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Enteropathy-associated T-cell lymphoma is usually a fast-growing (aggressive) lymphoma. Common complications of enteropathy-associated T-cell lymphoma include ulcer, obstruction, and perforation of small intestine. Prognosis is generally poor.
Natural History
- Enteropathy-associated T-cell lymphoma is usually a fast-growing (aggressive) lymphoma.[1]
- It is associated with celiac disease (sprue).
- Most adults are diagnosed with celiac disease at the same time as their lymphoma or shortly before their lymphoma is diagnosed.
- Enteropathy-associated T-cell lymphoma may spread to the liver, spleen, lymph nodes, gallbladder, stomach, colon or skin.
Complications
- Ulcer in small intestine
- Obstruction of small intestine
- Perforation of small intestine
Prognosis
- The prognosis for people with enteropathy-associated T-cell lymphoma is often not very good.[1][3]
- Recurrences most frequent in the small intestine.[4]
- The most influential prognostic factor is bulky nature of disease, defined by a tumor mass greater than 5 cm. [5] [6]
- Autologous stem cell transplantation is a useful way of treatment for selected patients with enteropathy-associated T-cell lymphoma and can control disease progress.
References
- ↑ 1.0 1.1 1.2 Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016
- ↑ Kabul S, Uğraş N, Yerci Ö, Öztürk E (2018). "Perforation of the small intestine caused by enteropathy-associated T cell lymphoma". Turk J Surg. 34 (3): 253–255. doi:10.5152/turkjsurg.2017.3278. PMC 6173604. PMID 30302434.
- ↑ Nijeboer P, de Baaij LR, Visser O, Witte BI, Cillessen SA, Mulder CJ, Bouma G (June 2015). "Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort". Am. J. Hematol. 90 (6): 493–8. doi:10.1002/ajh.23992. PMID 25716069.
- ↑ Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 27, 2016
- ↑ Delabie J, et al. (July 2011). "Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project". Blood. 118 (148): 148. doi:10.1182/blood-2011-02-335216.
- ↑ Kumar, A.; Burger, I. A.; Zhang, Z.; Drill, E. N.; Migliacci, J. C.; Ng, A.; LaCasce, A.; Wall, D.; Witzig, T. E.; Ristow, K.; Yahalom, J.; Moskowitz, C. H.; Zelenetz, A. D. (2016). "Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes". Haematologica. 101 (10): 1237–1243. doi:10.3324/haematol.2016.141846. ISSN 0390-6078.